SOMATOSTATIN RECEPTOR SCINTIGRAPHY IN NON-MEDULLARY THYROID-CANCER

Authors
POSTEMA PTE DEHERDER WW REUBI JC OEI HY KWEKKEBOOM DJ BRUINING HJ BONJER J VANTOOR H HENNEMANN G KRENNING EP
Citation
Pte. Postema et al., SOMATOSTATIN RECEPTOR SCINTIGRAPHY IN NON-MEDULLARY THYROID-CANCER, Digestion, 57, 1996, pp. 36-37
Citations number
6
Categorie Soggetti
Gastroenterology & Hepatology
Journal title
Digestion → ACNP
ISSN journal
00122823
Volume
57
Year of publication
1996
Supplement
1
Pages
36 - 37
Database
ISI
SICI code
0012-2823(1996)57:<36:SRSINT>2.0.ZU;2-A
Abstract
8 patients with papillary cancer (4 with metastases, 4 in remission), 7 follicular cancer patients (6 with metastases), 2 patients with anap lastic thyroid cancer, and 4 other non-medullary thyroid cancer patien ts all received an intravenous bolus injection of 220 MBq [In-111-DTPA -D-Phe(1)]octreotide. Planar anterior and posterior gamma camera image s of head-neck, chest and abdomen were obtained 24 and 48 h after inje ction. All primary cancers showed [In-111-DTPA-D-Phe(1)]octreotide upt ake; none occurred in patients in remission. The results were compared with conventional radio-iodine scintigraphy in patients with metastas ised, differentiated thyroid cancer.